SangerSequencing[1]
shape-element-one[1]
shape-element-two[1]
aBOUT

Not stopping until human disease is understood

Every answer we deliver is grounded in enduring expertise, collaboration, and a commitment to help make complex genomic information more meaningful for patients and providers.

Principles

SuperLab1[1]

Why We Exist

Advancing genomic understanding matters most when it helps improve care for patients and families.
SuperLab2[1]

Shared Knowledge

Genomic discovery is strengthened with openness, collective learning, and ongoing contribution to the broader community.
Multi-racial group of scientists researching and teamworking in laboratory

Scientific Rigor

Accuracy, consistency, and disciplined scientific methods are foundational to how we deliver genomic insights.

Built Through Experience

Counter statistics

20,000
Cases
In landmark methodology study (2016)
60,000
Square feet
State-of-the-art, CLIA/CAP certified custom facility
25+
Years
Pioneering genetic diagnostics since 1999
13129cd91c5a5d45821f6d297be4fcbf5da82bf4_86b1b6
1d31617ebec86937d6a1be05a2740e34247ae372_ff556a
ai-powered-care-logo
df35d9a0414d40f2d8641c8880d5b31d1f9b9ef9_f5083f

History

Ambry has a long history of industry firsts – from clinical exome testing, to large studies innovating testing methodology, to purpose-built laboratory infrastructure, to creating a database that shares genomic insights in service of understanding human disease.

But what defines us most is not a list of firsts. It is a longstanding commitment to advancing genomics in ways that support patients and families who rely on this important information.
about-super-lab-image_ff2a5d
ed8165161fac07aec180789548e930ed80c529a4 (1)

Super Lab

In 2016, Ambry built a customized a 60,000 square foot state-of-the-art facility, designed to increase efficiency, precision, and quality while reducing the potential for human error. This highly-automated CLIA/ CAP certified lab produces some of the fastest turn-around-times in the industry, without compromising accuracy and specificity.

  • 24/7 lab operation protected by one of the largest industrial generators
  • DNA fingerprinting of each specimen before and after testing for scalable sample tracking
  • “Zero-vibration flooring” built to withstand seismic tremors, further reducing the potential for error
  • Highly automated workflows to maximize consistency and reproducibility
charlie_dunlop[1]
FOUNDER

Charles L.M. Dunlop

In 1999, Charles “Charlie” Dunlop founded Ambry Genetics to build a company deeply committed to restoring the balance between open science and commercial interests — one driven by scientific rigor, relentlessly pursuing genomic answers, delivered with the best quality customer service.

Charlie realized this vision by launching some of the industry’s most useful diagnostic tests. He remains deeply connected to the minds and hearts of patients, understanding that access to information is just as important as quality science in finding the best treatment.